Acadia wins FDA nod for Rett syndrome therapy (NASDAQ:ACAD)
Grandbrothers Acadia Pharmaceuticals (NASDAQ:ACAD) announced late Friday that the FDA greenlighted trofinetide under the brand name Daybue to treat the ...
Grandbrothers Acadia Pharmaceuticals (NASDAQ:ACAD) announced late Friday that the FDA greenlighted trofinetide under the brand name Daybue to treat the ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.